BackgroundOne challenge to achieving Lymphatic filariasis (LF) elimination is the persistent coverage-compliance gap during annual mass drug administration (MDA) and the risk of ongoing transmission among never treated individuals. Our analysis examined factors associated with individuals who were never treated during MDA. MethodsData were derived from two cross-sectional surveys cond... https://www.sukrensi.com/